Efficacy and safety of GV1001 in patients with moderate-to-severe Alzheimer's disease already receiving donepezil: a phase 2 randomized, double-blind, placebo-controlled, multicenter clinical trial.

Seong-Ho KohHyuk Sung KwonSeong Hye ChoiJee Hyang JeongHae Ri NaChan Nyoung LeeYoungSoon YangAe Young LeeJae-Hong LeeKyung Won ParkHyun Jeong HanByeong C KimJin Se ParkJee-Young LeeSangjae KimKyu-Yong Lee

Published in: Alzheimer's research & therapy (2021)

ClinicalTrials.gov NCT03184467 . Registered on June 12, 2017.

Keyphrases

double blind
placebo controlled
clinical trial
phase ii
phase iii
study protocol
phase ii study
cognitive decline
high intensity
early onset
open label
randomized controlled trial